MedTrace Logo

Study to Investigate the Safety, Tolerability and Pharmacokinetics of AZD1940

NCT00689780 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2010-12-10

No results posted yet for this study

Summary

A Phase I, Multi-Centre, Randomised, Double-blind, Placebo-controlled Study to Investigate the Safety, Tolerability and Pharmacokinetics of AZD1940, Including an Interaction Study, After Administration of Oral Multiple Ascending Doses in Adult Subjects with Chronic Low Back Pain

Conditions

  • Low Back Pain

Interventions

DRUG

AZD1940

Oral solution Multiple ascending dose given orally once daily at day 1-12

DRUG

Midazolam

Oral solution given orally once daily on day -1 and day 14

Sponsors & Collaborators

Principal Investigators

  • Janet Post · AstraZeneca R&D SödertäljeSE

  • Wolfgang Kühn · Quintiles AB Phase 1 Services Strandbodgatan Uppsala, Sweden+

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2008-11-30
Completion
2008-11-30

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00689780 on ClinicalTrials.gov